Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aragon Surgical, a venture backed emerging medical device company, has received FDA clearance for the IntelliSeal OS12, the first instrument in its platform of radio frequency products that will cross a broad array of specialties.
Subscribe to our email newsletter
The OS12 was designed with gynecologists for use in abdominal hysterectomy. The IntelliSeal product line utilizes proprietary TissueSense technology in all of its electrosurgical instruments and systems. This energy delivery platform serves as the foundation for several open and laparoscopic surgical instruments. All IntelliSeal electrosurgical systems are designed to reduce operative time and improve patient safety.
Aragon Surgical plans to introduce additional products that utilize the proprietary TissueSense technology in 2009.
Roseanne Varner, president and CEO of Aragon Surgical, said: “We are very excited about introducing this unique surgical device to gynecologists. Feedback from both physician users and potential users on the obvious advantages of this device has been very positive.”